Defending Science Meetings

Scientific associations say new legislation that limits federal funding for conferences will hurt research.

Written byBeth Marie Mole
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

At least eight scientific associations are banding together to oppose the Government Spending Accountability (GSA) Act—which aims to limit government funding of conferences and meetings—over concern that it could stifle scientific collaboration.

If enacted, the act—which passed in the House this month (September 11) and is expected to go before the Senate this fall—will cap federal agency spending on conferences at $500,000, require that each agency file quarterly reports on conference-related expenditures, and slash travel budgets by approximately 30 percent. The act aims to cut down on frivolous government spending, but many scientists worry that such cost-cutting measures will severely reduce the number of National Institutes of Health (NIH), National Science Foundation (NSF), and Department of Energy (DOE) researchers that attend scientific conferences—stunting the open exchange of knowledge and have an overall chilling effect on research progress.

Judith S. Bond, president of the Federation of American Societies for Experimental Biology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies